Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Confirmed diagnosis of ulcerative colitis (UC) at least 3 months' duration prior to screening
Moderately to severely active UC as assessed by the modified Mayo score
Documentation of an inadequate response, loss of response, or intolerance to a treatment course of 1 or more of the following standard of care medications: oral 5-aminosalicylic acids, corticosteroids, immunomodulators, anti-tumor necrosis factor (TNF) agents, integrin inhibitors\[SA1\]
Documentation of prior treatment with corticosteroids for ≥ 4 weeks
Males and females must agree to follow specific methods of contraception, if applicable
You may not be if
Current diagnosis of Crohn's disease (CD) or diagnosis of indeterminate colitis (IC), ischemic colitis, or pseudomembranous colitis
Current evidence of fulminant colitis, abdominal abscess, toxic megacolon, or bowel perforation
History or evidence of any extensive colonic resection, or subtotal or total colectomy
Women who are pregnant or breastfeeding
Prior exposure to BMS-986165 or a tyrosine kinase 2 (TYK2) inhibitor
